Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta-Reference-Cited by-同舟云学术

Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta

Published:1995-04 Issue:8 Volume:114 Page:1587-1594
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Yu Sheu-Meei,Kuo Sheng-Chu

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1995.tb14943.x/fullpdf

Reference37 articles.

1. Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors;BEAVO;Trends Pharmacol. Sci.,1990

2. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilation of pig coronary arteries;BENY;Blood Vessels,1988

3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding;BRADFORD;Anal. Biochem.,1976

4. Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells;BROCK;Hypertension,1985

5. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies in human bronchus;CORTIJO;Br. J. Pharmacol.,1993

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Composition of Methanol Extracts from Leaves and Flowers of Anemonopsis macrophylla (Ranunculaceae);International Journal of Molecular Sciences;2024-01-12

2. The DNA barcode identification of Dalbergia odorifera T. Chen and Dalbergia tonkinensis Prain;BMC Plant Biology;2023-11-07

3. Soluble guanylate cyclase agonist, isoliquiritigenin attenuates renal damage and aortic calcification in a rat model of chronic kidney failure;Life Sciences;2023-03

4. Secondary Metabolites of Plants as Modulators of Endothelium Functions;International Journal of Molecular Sciences;2021-03-03

5. New flavonoid-based compound synthesis strategy for antihypertensive drug development;Life Sciences;2020-05